Table 3.
Summary of recommendations
| Amino Acid PET (MET, FET, FDOPA) | FDG PET | Other PET Tracers | Oxford Level of Evidence | |
|---|---|---|---|---|
| Identification of newly diagnosed BM | (++) | − | na | 3 |
| Differential diagnosis of newly diagnosed BM | (++) | − | na | 3 |
| Differentiation of radiation-induced changes from BM recurrence | ++ * | + | na | 2 |
| Differentiation of immunotherapy-related changes from BM recurrence | (++) | na | na | 3 |
| Assessment of treatment response | (++) | na | (++) | 3 |
++ high diagnostic accuracy; (++) high diagnostic accuracy, but limited data available; + limited diagnostic accuracy; − not helpful; na = only preliminary or no data available; *increased accuracy when using dynamic FET PET